Drug intelligence / Profile preview

alpha-ketoglutarate

Development stage
Unknown
Lead developer
Rejuvant
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

Alpha-ketoglutarate is a naturally occurring compound in the body and a key intermediate in the citric acid (Krebs) cycle. It plays a central role in cellular energy production and metabolism. Alpha-ketoglutarate is involved in amino acid synthesis and nitrogen balance and acts as a precursor to glutamine. It also functions as an antioxidant and participates in various metabolic pathways that regulate carbon, nitrogen, ammonia levels, and reduce reactive oxygen species. Clinically and as a supplement, it has been used to support muscle protein synthesis (especially after trauma or surgery), improve kidney function (notably during hemodialysis), aid recovery from injury or surgery by preventing muscle breakdown, potentially enhance athletic performance by reducing ammonia toxicity during exercise (though evidence for this use is limited), support healthy aging/longevity based on preclinical studies showing lifespan extension in animals, improve skin barrier function when applied topically or taken orally due to effects on skin proteins like involucrin/filaggrin/serine palmitoyl transferase; it may also help manage liver disease-related hyperammonemia[1][4][5][6][8].

Brand names
Rejuvant
Other names
α-ketoglutaratealpha-ketoglutaric acid2-oxopentanedioic acidoxoglutaric acid2-oxoglutarate2-ketoglutaric acidpentanedioic acid 2-oxo-α-oxoglutarateketoglutarate
02

Targets

PHD1 (Prolyl hydroxylase domain-containing protein 1)Neuraminidase

Beyond the preview

Go deeper on alpha-ketoglutarate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on alpha-ketoglutarate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call